Suraksha Diagnostic share price
You have to be logged in to add this to Watchlist.- ₹257.20(-3.85%)March 6, 2026 14:53:53 PM IST
- NSE
- BSE
- Vol : 13.74 K (NSE + BSE)Last 20 day avg : 18.28 K
Suraksha Diagnostic is trading -3.85% lower at Rs 257.20 as compared to its last closing price. Suraksha Diagnostic has been trading in the price range of 263.00 & 255.25. Suraksha Diagnostic has given -2.15% in this year & -6.10% in the last 5 days. Suraksha Diagnostic has TTM P/E ratio 42.20 as compared to the sector P/E of 24.35.The company posted a net profit of 7.52 Crores in its last quarter.Listed peers of Suraksha Diagnostic include Narayana Hrudayalaya (-1.20%), Max Healthcare Institute (-1.36%), Apollo Hospitals Enterprise (-0.55%).The Mutual Fund holding in Suraksha Diagnostic was at 19.45% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Suraksha Diagnostic was at 13.46% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Mar 06, 2026, 09:26 AM UTC
- Debt To EquityHigher than industry0.42The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation2.78The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Narayana Hrudayalaya | Bearish | 1,747.20 | -1.20 | 35,705.92 | 47.66 | 10.51 | 0.24 | 59.03 |
| Max Healthcare Institute | Bearish | 1,043.30 | -1.36 | 1,01,546.77 | 93.43 | 11.21 | 0.14 | 29.50 |
| Apollo Hospitals Enterprise | Bullish | 7,733.15 | -0.55 | 1,11,190.83 | 71.09 | 12.56 | 0.26 | 83.18 |
| Global Health | Bearish | 1,110.50 | -0.07 | 29,845.14 | 61.73 | 9.45 | 0.04 | 18.41 |
| Fortis Healthcare | Moderately Bearish | 893.70 | -2.95 | 67,474.28 | 80.04 | 7.64 | 0.11 | 25.92 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-05 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-28 | Audited Results & Final Dividend |
| 2025-02-08 | Quarterly Results |
- IndustryHealthcare Facilities
- ISININE877V01027
- BSE Code544293
- NSE CodeSURAKSHA
Suraksha Diagnostic is trading at 257.20 as on Fri Mar 06 2026 09:23:53. This is -3.85% lower as compared to its previous closing price of 267.50.
The market capitalization of Suraksha Diagnostic is 1333.53 Cr as on Fri Mar 06 2026 09:23:53.
The 52 wk high for Suraksha Diagnostic is 353.65 whereas the 52 wk low is 227.95
Suraksha Diagnostic can be analyzed on the following key metrics -
- TTM P/E: 42.20
- Sector P/E: 24.35
- Dividend Yield: 0.00%
- D/E ratio: -
Suraksha Diagnostic reported a net profit of 31.82 Cr in 2025.
The Mutual Fund Shareholding was 19.45% at the end of 31 Dec 2025.